Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients
NCT05683015
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis Vulgaris
Interventions
PROCEDURE:
Venapuncture
PROCEDURE:
Patient questionnaires
Sponsor
University Hospital, Ghent